We have located links that may give you full text access.
Highly phosphorescence iridium complexes and their application in organic light-emitting devices.
Journal of the American Chemical Society 2003 July 24
A new series of iridium(III) mixed ligand complexes TBA[Ir(ppy)(2)(CN)(2)] (1), TBA[Ir(ppy)(2)(NCS)(2)] (2), TBA[Ir(ppy)(2)(NCO)(2)] (3), and [Ir(ppy)(2)(acac)] (4) (ppy = 2-phenylpyridine; acac = acetoylacetonate, TBA = tetrabutylammonium cation) have been developed and fully characterized by UV-vis, emission, IR, NMR, and cyclic voltammetric studies. The lowest energy MLCT transitions are tuned from 463 to 494 nm by tuning the energy of the HOMO levels. These complexes show emission maxima in the blue, green, and yellow region of the visible spectrum and exhibit unprecedented phosphorescence quantum yields, 97 +/- 3% with an excited-state lifetimes of 1-3 micros in dichloromethane solution at 298 K. The near-unity quantum yields of these complexes are related to an increased energy gap between the triplet emitting state and the deactivating e(g) level that have been achieved by meticulous selection of ligands having strong ligand field strength. Organic light-emitting devices were fabricated using the complex 4 doped into a purified 4,4'-bis(carbazol-9-yl)biphenyl host exhibiting a maximum of the external quantum efficiencies of 13.2% and a power efficiency of 37 lm/W for the 9 mol % doped system.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app